Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
This study is ongoing, but not recruiting participants.
Study NCT00081159
Information provided by National Cancer Institute (NCI)
First Received: April 7, 2004
Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
